glp 1 agonist saxenda Order Pens (Liraglutide) from Canada Article » ProAct
Description
Brazeau, P
Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, et al
during the conduct of the study
2025 doi: 10.1016/S2213-8587(24)00316-4
Figure 15: Photograph of Professor Roger Unger, credit The Lancet
While it looks at a very different (and more severe) health risk, the study is similar to Ozempics case in the sense that both aim to balance the trade-off between treating new and existing patients under supply uncertainty
